Polysaccharide-Based Delivery Systems for CRISPR/Cas Gene Therapy: Overcoming Challenges and Advancing Pharmaceutical Solutions

References

1. Ahmad A. Gulraiz Y. Ilyas S. Bashir S. Polysaccharide based nano materials: Health implications. Food Hydrocoll. Health 2022 2 100075 10.1016/j.fhfh.2022.100075
   [Google Scholar]
2. Benalaya I. Alves G. Lopes J. Silva L.R. A review of natural polysaccharides: Sources, characteristics, properties, food, and pharmaceutical applications. Int. J. Mol. Sci. 2024 25 2 1322 10.3390/ijms25021322 38279323
   [Google Scholar]
3. Xu X. Liu Y. Polysaccharide-based nanocarriers in gene therapy: A safe and effective alternative to viral vectors. J. Mol. Pharm. 2022 19 3 1124 1136
   [Google Scholar]
4. Dubey A.K. Mostafavi E. Biomaterials-mediated CRISPR/Cas9 delivery: Recent challenges and opportunities in gene therapy. Front Chem. 2023 11 1259435 10.3389/fchem.2023.1259435 37841202
   [Google Scholar]
5. Chen C. Zhong W. Du S. Li Y. Zeng Y. Liu K. Yang J. Guan X. Han X. Intelligent nanotherapeutic strategies for the delivery of CRISPR system. Acta Pharm. Sin. B 2023 13 6 2510 2543 10.1016/j.apsb.2022.12.013 37425051
   [Google Scholar]
6. Kazemian P. Yu S.Y. Thomson S.B. Birkenshaw A. Leavitt B.R. Ross C.J.D. Lipid-nanoparticle-based delivery of CRISPR/Cas9 genome-editing components. Mol. Pharm. 2022 19 6 1669 1686 10.1021/acs.molpharmaceut.1c00916 35594500
   [Google Scholar]
7. Kaupbayeva B. Tsoy A. Safarova Yantsen Y. Nurmagambetova A. Murata H. Matyjaszewski K. Askarova S. Unlocking genome editing: Advances and obstacles in CRISPR/Cas delivery technologies. J. Funct. Biomater. 2024 15 11 324 10.3390/jfb15110324 39590528
   [Google Scholar]
8. Caprifico A.E. Foot P.J.S. Polycarpou E. Calabrese G. Advances in chitosan-based CRISPR/Cas9 delivery systems. Pharmaceutics 2022 14 9 1840 10.3390/pharmaceutics14091840 36145588
   [Google Scholar]
9. Borrelli A. Tornesello A. Tornesello M. Buonaguro F. Cell penetrating peptides as molecular carriers for anti-cancer agents. Molecules 2018 23 2 295 10.3390/molecules23020295 29385037
   [Google Scholar]
10. Liu C. Zhang L. Liu H. Cheng K. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications. J. Control. Release 2017 266 17 26 10.1016/j.jconrel.2017.09.012 28911805
    [Google Scholar]
11. Liu Z. Wang S. Tapeinos C. Torrieri G. Känkänen V. El-Sayed N. Python A. Hirvonen J.T. Santos H.A. Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines. Adv. Drug Deliv. Rev. 2021 174 576 612 10.1016/j.addr.2021.05.018 34019958
    [Google Scholar]
12. Yetisgin A.A. Cetinel S. Zuvin M. Kosar A. Kutlu O. Therapeutic nanoparticles and their targeted delivery applications. Molecules 2020 25 9 2193 10.3390/molecules25092193 32397080
    [Google Scholar]
13. Abourehab M.A.S. Rajendran R.R. Singh A. Pramanik S. Shrivastav P. Ansari M.J. Manne R. Amaral L.S. Deepak A. Alginate as a promising biopolymer in drug delivery and wound healing: A review of the state-of-the-art. Int. J. Mol. Sci. 2022 23 16 9035 10.3390/ijms23169035 36012297
    [Google Scholar]
14. Li T. Yang Y. Qi H. Cui W. Zhang L. Fu X. He X. Liu M. Li P. Yu T. CRISPR/Cas9 therapeutics: Progress and prospects. Signal Transduct. Target. Ther. 2023 8 1 36 10.1038/s41392‑023‑01309‑7 36646687
    [Google Scholar]
15. Deneault E. Recent therapeutic gene editing applications to genetic disorders. Curr. Issues Mol. Biol. 2024 46 5 4147 4185 10.3390/cimb46050255 38785523
    [Google Scholar]
16. Rabaan A.A. AlSaihati H. Bukhamsin R. Bakhrebah M.A. Nassar M.S. Alsaleh A.A. Alhashem Y.N. Bukhamseen A.Y. Al-Ruhimy K. Alotaibi M. Alsubki R.A. Alahmed H.E. Al-Abdulhadi S. Alhashem F.A. Alqatari A.A. Alsayyah A. Farahat R.A. Abdulal R.H. Al-Ahmed A.H. Imran M. Mohapatra R.K. Application of CRISPR/Cas9 technology in cancer treatment: A future direction. Curr. Oncol. 2023 30 2 1954 1976 10.3390/curroncol30020152 36826113
    [Google Scholar]
17. Chemello F. Bassel-Duby R. Olson E.N. Correction of muscular dystrophies by CRISPR gene editing. J. Clin. Invest. 2020 130 6 2766 2776 10.1172/JCI136873 32478678
    [Google Scholar]
18. Smith R. Chitosan-mediated delivery of CRISPR/Cas9 for cancer gene therapy. J. Gene Delivery 2023
    [Google Scholar]
19. Liu X. Hyaluronic acid-based nanoparticles for targeted CRISPR delivery. Biomater. Sci. 2022
    [Google Scholar]
20. Alallam B. Altahhan S. Taher M. Mohd Nasir M.H. Doolaanea A.A. Electrosprayed alginate nanoparticles as CRISPR plasmid DNA delivery carrier: preparation, optimization, and characterization. Pharmaceuticals 2020 13 8 158 10.3390/ph13080158 32707857
    [Google Scholar]
21. Puccetti M. Pariano M. Schoubben A. Giovagnoli S. Ricci M. Biologics, theranostics, and personalized medicine in drug delivery systems. Pharmacol. Res. 2024 201 107086 10.1016/j.phrs.2024.107086 38295917
    [Google Scholar]
22. Emerging Technologies and Innovation in Manufacturing Regenerative Medicine Therapies: Proceedings of a Workshop—in Brief. Washington (DC) National Academies Press (US) 2024
    [Google Scholar]